Next Article in Journal
Desialylated Mesenchymal Stem Cells-Derived Extracellular Vesicles Loaded with Doxorubicin for Targeted Inhibition of Hepatocellular Carcinoma
Next Article in Special Issue
Improving the Efficiency of Precise Genome Editing with CRISPR/Cas9 to Generate Goats Overexpressing Human Butyrylcholinesterase
Previous Article in Journal
Noradrenaline and Movement Initiation Disorders in Parkinson’s Disease: A Pharmacological Functional MRI Study with Clonidine
Previous Article in Special Issue
Golden Syrian Hamster Models for Cancer Research
 
 
Review
Peer-Review Record

Modelling Neurological Diseases in Large Animals: Criteria for Model Selection and Clinical Assessment

Cells 2022, 11(17), 2641; https://doi.org/10.3390/cells11172641
by Samantha L. Eaton 1,*,†, Fraser Murdoch 1,†, Nina M. Rzechorzek 2,†, Gerard Thompson 3,4, Claudia Hartley 1, Benjamin Thomas Blacklock 1, Chris Proudfoot 5, Simon G. Lillico 1, Peter Tennant 5, Adrian Ritchie 5, James Nixon 5, Paul M. Brennan 6, Stefano Guido 1,7, Nadia L. Mitchell 8, David N. Palmer 8, C. Bruce A. Whitelaw 1, Jonathan D. Cooper 9 and Thomas M. Wishart 1,*
Reviewer 1:
Reviewer 2: Anonymous
Cells 2022, 11(17), 2641; https://doi.org/10.3390/cells11172641
Submission received: 25 July 2022 / Revised: 19 August 2022 / Accepted: 22 August 2022 / Published: 25 August 2022

Round 1

Reviewer 1 Report

The authors summarized the neurological assessment protocols on neuroanatomical dysfunction large animal species, which provides direction and guidance for neurological disease modelling. The review is comprehensive, and the figures are well drawn delivering clear information. Only some minor points need to be clarified.

Table 1: lack of hemorhagic stroke in category "vascular". And lack of AD and PD, which are the main types of neurodegenerative diseases.

 

 

Author Response

Please see the attachment

Author Response File: Author Response.pdf

Reviewer 2 Report

 

Cells

Review

Samantha L Eaton et al.

Modelling neurological diseases in large animals: criteria for model selection and clinical assessment

Advances in neuroscience are crucial to keep our aging society healthy. The risk of memory loss and cognitive decline grows as people get older. One in six people will experience depression at some time in their life (according to WHO, APA); with women at all ages affected twice as much to develop neuro-psychiatric disorders. The brain is a very complex organ, and plenty rodent, genetic animal research has given invaluable information that has been transformed into medical knowledge. Until reliable alternative approaches for translational research are available and proven, the use of animal models for basic neuroscience is necessary. In the current review, Eaton et al. favorize the use of larger animals, i.e. livestock, to ‘bridge the translational gap’ to humans. In their overview, the authors summarize and describe the optimal use of e.g. sheep, and categorize neurological conditions following ‘vitamin d’ classifications. The review is very comprehensive including assessment strategies behavior, histology, imaging, and electrodiagnostic that have been used to study livestock for neurological analysis. Authors conclude with an advanced functional readout describing (sheep) disease models such as for Huntington or Epilepsy. It’s a novel, and very extensive review. What’s maybe missing, is a discussion, summarizing paragraph near the reviews end, that compares the authors arguments to rodent models, and includes a view on the current debate about reducing experimental animals overall. Please find minor comments below that might help to improve the manuscript.

 

For the title, I suggest to already include ‘sheep’ somewhere since a large part of the review is based on it.

The abstract needs a more stringent saying of the main points, and focus of the review; it could also already include a statements, conclusion. Please also use shorter sentences throughout the manuscript.

Please check English spelling, grammar, e.g. use ‘-‘ before (e.g. rodent-) derived, introduce abbreviations early (line 50, use ‘central’ nervous system, CNS, throughout; li 62, 89 ... 910), li 31, 58 etc. ‘in part due to’, animal model ‘for’ neurological disease, take out ‘human’ in front of patients, avert of double words, e.g. li33, effective, li182 ‘model’ etc.

 

Author Response

Please see the attachment

Author Response File: Author Response.pdf

Back to TopTop